ALPS Advisors’s Amylyx Pharmaceuticals AMLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-67,597
| Closed | -$239K | – | 1029 |
|
|
2025
Q1 | $239K | Buy |
67,597
+12,167
| +22% | +$43.1K | ﹤0.01% | 952 |
|
|
2024
Q4 | $210K | Buy |
+55,430
| New | +$210K | ﹤0.01% | 969 |
|
|
2024
Q3 | – | Sell |
-90,357
| Closed | -$172K | – | 999 |
|
|
2024
Q2 | $172K | Sell |
90,357
-48,893
| -35% | -$92.9K | ﹤0.01% | 956 |
|
|
2024
Q1 | $395K | Buy |
139,250
+89,522
| +180% | +$254K | ﹤0.01% | 636 |
|
|
2023
Q4 | $732K | Buy |
49,728
+32
| +0.1% | +$471 | 0.01% | 549 |
|
|
2023
Q3 | $910K | Buy |
49,696
+316
| +0.6% | +$5.79K | 0.01% | 490 |
|
|
2023
Q2 | $1.07M | Buy |
49,380
+5,724
| +13% | +$123K | 0.01% | 479 |
|
|
2023
Q1 | $1.28M | Sell |
43,656
-1,256
| -3% | -$36.9K | 0.01% | 393 |
|
|
2022
Q4 | $1.66M | Buy |
+44,912
| New | +$1.66M | 0.01% | 338 |
|